CAPRISA hosts delegation from Gilead Sciences

1 July 2022

CAPRISA hosted a delegation from Gilead Sciences on Thursday 23rd and Friday 24th June. Dr Alex Kintu, Director Clinical Development at Gilead Sciences, led the delegation on their visit to the CAPRISA Vulindlela Research site on 23rd June. The delegation held discussions with Professor Quarraisha Abdool Karim, CAPRISA Associate Scientific Director, Dr Disebo Potloane, Site Director and research staff.  Guests also had an opportunity to visit the historic Mandela  Capture Site in Howick. 

On 24th June Gilead officials visited the CAPRISA eThekwini Research site (ECRS) and uMlazi Research Clinic.  Dr Leila Mansoor, Senior Scientist and Dr Ishana Harkoo, Research Clinician engaged with Gilead officials at ECRS.  Site Director Professor Daya Moodley led the discussions at the uMlazi Research site with Dr Moupali Das, Exec Director HIV Clinical Research, Gilead Sciences; Mr Daniel Masjuan, Snr Clinical Trial Manager, Gilead; and        Dr Jenna Yager, Postdoc Fellow at the University of Colorado.  

The delegation gained insight into CAPRISA’s key HIV prevention and TB-HIV research and studies currently underway at the sites.